CBT
Cabot Corporation Basic Materials - Specialty Chemicals Investor Relations →
Cabot Corporation (CBT) closed at $91.80 as of 2026-06-19, trading 19.5% above its 200-week moving average of $76.83. The stock moved further from the line this week, up from 14.2% last week. With a 14-week RSI of 72, CBT is in overbought territory.
Trading volume is running at 1.6x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.04 ratio) is neutral — neither side is clearly dominating.
Over the past 2332 weeks of data, CBT has crossed below its 200-week moving average 36 times. On average, these episodes lasted 17 weeks. Historically, investors who bought CBT at the start of these episodes saw an average one-year return of +26.2%.
With a market cap of $4.7 billion, CBT is a mid-cap stock. The company generates a free cash flow yield of 7.9%, which is healthy. Return on equity stands at 20.0%, indicating strong profitability. The stock trades at 3.0x book value.
The company has been aggressively buying back shares, reducing its share count by 6.1% over the past three years.
Over the past 33.5 years, a hypothetical investment of $100 in CBT would have grown to $3247, compared to $3097 for the S&P 500. That represents an annualized return of 10.9% vs 10.8% for the index — confirming CBT as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: CBT vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After CBT Crosses Below the Line?
Across 25 historical episodes, buying CBT when it crossed below its 200-week moving average produced an average return of +23.0% after 12 months (median +22.0%), compared to +13.4% for the S&P 500 over the same periods. 71% of those episodes were profitable after one year. After 24 months, the average return was +50.2% vs +20.6% for the index.
Each line shows $100 invested at the moment CBT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices CBT would reach each dislocation threshold.
Dislocation Price Levels
Prices where CBT's Bean Score would hit each σ threshold. Valid until next earnings report: 2026-08-03.
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $74.03 | Unusually cheap — potential buy zone |
| Value | +1σ | $77.41 | Cheap vs. own history |
| Fair Value | +0σ | $81.12 | Historical mean behavior |
| Expensive | -1σ | $85.21 | Expensive vs. own history |
| Deep Expensive | -2σ | $89.73 | Unusually expensive — potential trim zone |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from CBT's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
CBT has crossed below its 200-week MA 36 times with an average 1-year return of +26.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Oct 1981 | Feb 1983 | 69 | 38.4% | -4.8% | +6115.3% |
| Aug 1983 | Sep 1983 | 5 | 2.2% | -4.9% | +6236.0% |
| Dec 1983 | Jan 1984 | 4 | 3.6% | +0.5% | +6266.9% |
| Jan 1984 | Mar 1984 | 5 | 5.5% | +18.9% | +6236.0% |
| Mar 1984 | Aug 1984 | 23 | 11.9% | +8.3% | +6236.0% |
| Aug 1985 | Oct 1985 | 9 | 16.3% | +25.9% | +6458.9% |
| Jan 1986 | Feb 1986 | 5 | 5.1% | +39.2% | +6499.8% |
| Mar 1986 | Mar 1986 | 1 | 1.6% | +49.1% | +6403.7% |
| Nov 1987 | Dec 1987 | 1 | 3.5% | +35.8% | +5546.9% |
| Oct 1989 | Nov 1989 | 2 | 2.6% | -20.2% | +4399.4% |
| Jan 1990 | Mar 1991 | 60 | 31.7% | -12.7% | +4267.2% |
| Apr 1991 | Sep 1991 | 20 | 10.9% | +48.4% | +4159.0% |
| Nov 1991 | Dec 1991 | 5 | 10.1% | +55.8% | +4422.5% |
| Aug 1998 | Oct 1998 | 9 | 12.4% | -3.7% | +1105.5% |
| Jan 1999 | Apr 1999 | 14 | 25.1% | -6.5% | +1040.7% |
| May 1999 | Mar 2000 | 43 | 29.2% | +5.2% | +1027.5% |
| Oct 2000 | Oct 2000 | 1 | 25.4% | +259.7% | +1378.3% |
| Sep 2002 | Oct 2002 | 5 | 9.9% | +39.0% | +618.2% |
| Feb 2003 | Mar 2003 | 6 | 9.3% | +40.5% | +572.8% |
| Apr 2003 | Apr 2003 | 1 | 1.4% | +43.2% | +565.9% |
| May 2005 | Jun 2005 | 6 | 8.4% | +22.3% | +409.9% |
| Sep 2007 | Oct 2007 | 1 | 0.5% | -9.2% | +307.3% |
| Oct 2007 | Feb 2010 | 120 | 74.3% | -28.7% | +314.8% |
| May 2010 | Jun 2010 | 3 | 5.7% | +53.0% | +378.2% |
| Jun 2010 | Jul 2010 | 5 | 15.8% | +48.1% | +399.7% |
| Sep 2011 | Oct 2011 | 3 | 7.6% | +56.7% | +418.0% |
| Dec 2014 | Dec 2014 | 1 | 3.3% | +6.4% | +205.5% |
| Jun 2015 | Nov 2015 | 23 | 22.6% | +14.6% | +190.3% |
| Dec 2015 | Feb 2016 | 10 | 10.2% | +33.4% | +187.2% |
| Oct 2018 | Oct 2018 | 1 | 1.9% | -2.3% | +131.0% |
| Nov 2018 | Jan 2021 | 111 | 57.1% | +3.0% | +135.4% |
| Jan 2021 | Feb 2021 | 1 | 4.4% | +29.9% | +135.5% |
| May 2025 | May 2025 | 3 | 0.5% | +18.7% | +27.9% |
| Jun 2025 | Jun 2025 | 1 | 1.7% | +28.5% | +28.5% |
| Jul 2025 | Aug 2025 | 3 | 4.3% | N/A | +25.5% |
| Sep 2025 | Apr 2026 | 29 | 19.6% | N/A | +24.4% |
| Average | 17 | — | +26.2% | — |
Frequently Asked Questions
Is CBT below its 200-week moving average?
No. Cabot Corporation (CBT) is currently 19.5% above its 200-week moving average of $76.83. It would need to fall to $76.83 to cross below the line.
What is CBT's 200-week moving average price?
Cabot Corporation's 200-week moving average is $76.83 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when CBT drops below its 200-week moving average?
CBT has crossed below its 200-week moving average 36 times in our data. On average, buying at that moment produced a one-year return of +26.2%. These dips have historically been decent entry points. These episodes lasted 17 weeks on average.
Is CBT a good value right now?
Here's what our data says about CBT as of 2026-06-19: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 72 (overbought). Free cash flow yield is 7.9%. Return on equity is 20.0%. Price-to-book is 3.0x. This is not a buy or sell recommendation — always do your own research.
How does CBT compare to the S&P 500?
Over the past 33.5 years, $100 invested in CBT would have grown to $3247, compared to $3097 for the S&P 500. That's 10.9% annualized vs 10.8% for the index. CBT has outperformed the broader market over this period.
Does CBT pay a dividend?
Yes. Cabot Corporation currently pays a dividend yield of 206.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19